Literature DB >> 17435183

Notes on the kidney and its diseases for the neurologist.

Michael S Zandi1, Alasdair J Coles.   

Abstract

To save their patients from dialysis and transplantation, neurologists need simply remain alert to the possibility of renal failure, particularly in the context of systemic disease, diabetes, sepsis and drugs. Of the numerous territories shared by our respective specialities, we outline a pragmatic approach to the diagnosis and treatment of the vasculitides, underpinned by knowing which questions to ask, equally importantly when to ask them, and in the art of obtaining a tissue diagnosis. We consider the current evolving trial evidence that directs the usage of a growing arsenal of therapies in the induction and maintenance stages of vasculitis treatment, and extend this consideration to Lupus and Sjogren's.

Entities:  

Mesh:

Year:  2007        PMID: 17435183      PMCID: PMC2117828          DOI: 10.1136/jnnp.2006.091991

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  55 in total

1.  Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

Authors:  R N Maini; P C Taylor; J Szechinski; K Pavelka; J Bröll; G Balint; P Emery; F Raemen; J Petersen; J Smolen; D Thomson; T Kishimoto
Journal:  Arthritis Rheum       Date:  2006-09

2.  Interferon alfa treatment for Sjogren's syndrome associated neuropathy.

Authors:  S Yamada; K Mori; K Matsuo; A Inukai; Y Kawagashira; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

3.  Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.

Authors:  M Nakamura; Y Tanaka; T Satoh; M Kawai; M Hirakata; J Kaburaki; Y Kawakami; Y Ikeda; M Kuwana
Journal:  Rheumatology (Oxford)       Date:  2005-09-27       Impact factor: 7.580

4.  The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy.

Authors:  Keiko Mori; Masahiro Iijima; Haruki Koike; Naoki Hattori; Fumiaki Tanaka; Hirohisa Watanabe; Masahisa Katsuno; Asako Fujita; Ikuko Aiba; Akihiko Ogata; Toyokazu Saito; Kunihiko Asakura; Mari Yoshida; Masaaki Hirayama; Gen Sobue
Journal:  Brain       Date:  2005-07-27       Impact factor: 13.501

5.  Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.

Authors:  Emily C Somers; Wendy Marder; Gregory M Christman; Vladimir Ognenovski; W Joseph McCune
Journal:  Arthritis Rheum       Date:  2005-09

6.  Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Kirsten De Groot; Niels Rasmussen; Paul A Bacon; Jan Willem Cohen Tervaert; Conleth Feighery; Gina Gregorini; Wolfgang L Gross; Raashid Luqmani; David R W Jayne
Journal:  Arthritis Rheum       Date:  2005-08

7.  Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

Authors:  Mark C Genovese; Jean-Claude Becker; Michael Schiff; Michael Luggen; Yvonne Sherrer; Joel Kremer; Charles Birbara; Jane Box; Kannan Natarajan; Isaac Nuamah; Tracy Li; Richard Aranda; David T Hagerty; Maxime Dougados
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

Review 8.  Gene therapy in systemic lupus erythematosus.

Authors:  V C Kyttaris; P P Sfikakis; Y-T Juang; G C Tsokos
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

9.  Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Authors:  Susan L Hogan; Ronald J Falk; Hyunsook Chin; Jianwen Cai; Caroline E Jennette; J Charles Jennette; Patrick H Nachman
Journal:  Ann Intern Med       Date:  2005-11-01       Impact factor: 25.391

10.  Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Authors:  Philip Seo; Yuan-I Min; Janet T Holbrook; Gary S Hoffman; Peter A Merkel; Robert Spiera; John C Davis; Steven R Ytterberg; E William St Clair; W Joseph McCune; Ulrich Specks; Nancy B Allen; Raashid A Luqmani; John H Stone
Journal:  Arthritis Rheum       Date:  2005-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.